# Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses

> **NCT06245486** · NA · UNKNOWN · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Crispact®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06245486
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245486, "Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06245486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*